MXPA01011611A - Derivados de espiroimidazolidina, su prepracion, su uso y preparaciones farmaceuticas que los comprenden. - Google Patents

Derivados de espiroimidazolidina, su prepracion, su uso y preparaciones farmaceuticas que los comprenden.

Info

Publication number
MXPA01011611A
MXPA01011611A MXPA01011611A MXPA01011611A MXPA01011611A MX PA01011611 A MXPA01011611 A MX PA01011611A MX PA01011611 A MXPA01011611 A MX PA01011611A MX PA01011611 A MXPA01011611 A MX PA01011611A MX PA01011611 A MXPA01011611 A MX PA01011611A
Authority
MX
Mexico
Prior art keywords
preparation
pharmaceutical preparations
spiroimidazolidine
derivatives
spiroimidazolidine derivatives
Prior art date
Application number
MXPA01011611A
Other languages
English (en)
Inventor
Hans Ulrich Stilz
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of MXPA01011611A publication Critical patent/MXPA01011611A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
MXPA01011611A 1999-05-17 2000-05-06 Derivados de espiroimidazolidina, su prepracion, su uso y preparaciones farmaceuticas que los comprenden. MXPA01011611A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19922462A DE19922462A1 (de) 1999-05-17 1999-05-17 Spiro-imidazolidinderivate, ihre Herstellung ihre Verwendung und sie enthaltende pharmazeutische Präparate
PCT/EP2000/004090 WO2000069831A1 (en) 1999-05-17 2000-05-06 Spiroimidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them

Publications (1)

Publication Number Publication Date
MXPA01011611A true MXPA01011611A (es) 2003-09-10

Family

ID=7908208

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA01011611A MXPA01011611A (es) 1999-05-17 2000-05-06 Derivados de espiroimidazolidina, su prepracion, su uso y preparaciones farmaceuticas que los comprenden.

Country Status (28)

Country Link
US (1) US6399643B1 (es)
EP (1) EP1183241B1 (es)
JP (1) JP4686029B2 (es)
KR (1) KR100658962B1 (es)
CN (1) CN1221535C (es)
AR (1) AR023989A1 (es)
AT (1) ATE250038T1 (es)
AU (1) AU778814B2 (es)
BR (1) BR0011296B1 (es)
CA (1) CA2373433C (es)
CZ (1) CZ301467B6 (es)
DE (2) DE19922462A1 (es)
DK (1) DK1183241T3 (es)
ES (1) ES2204595T3 (es)
HK (1) HK1047104B (es)
HU (1) HU228917B1 (es)
IL (2) IL146276A0 (es)
MX (1) MXPA01011611A (es)
NO (1) NO320687B1 (es)
NZ (1) NZ515496A (es)
PL (1) PL201421B1 (es)
PT (1) PT1183241E (es)
RU (1) RU2245879C2 (es)
SI (1) SI1183241T1 (es)
TR (1) TR200103278T2 (es)
TW (1) TWI256386B (es)
WO (1) WO2000069831A1 (es)
ZA (1) ZA200109370B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10111877A1 (de) * 2001-03-10 2002-09-12 Aventis Pharma Gmbh Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE10134366A1 (de) * 2001-07-14 2003-01-23 Aventis Pharma Gmbh Verfahren zur Herstellung der enantiomeren Formen von 2-substituierten 2-(2,5-Dioxoimidazolidin-l-yl)-essigsäure- Derivaten
DE10137595A1 (de) * 2001-08-01 2003-02-13 Aventis Pharma Gmbh Neue Imidazolidinderivate, ihre Herstellung und ihre Verwendung
PL3326645T3 (pl) 2010-10-25 2020-09-21 Biogen Ma Inc. Sposoby określania różnic w aktywności integryn alfa-4 przez korelowanie różnic w poziomach sVCAM i/lub sMAdCAM

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4009506A1 (de) 1990-03-24 1991-09-26 Hoechst Ag Hydantoinderivate
DE4126277A1 (de) 1991-08-08 1993-02-11 Cassella Ag Hydantoinderivate
CA2127462C (en) 1992-01-13 1999-03-23 Roy R. Lobb Treatment for asthma
EP0625912B1 (en) 1992-02-12 1997-04-16 Biogen, Inc. Treatment for inflammatory bowel disease
DE4207254A1 (de) 1992-03-07 1993-09-09 Cassella Ag 4-oxo-2-thioxoimidazolidin-derivate
DE4213634A1 (de) 1992-04-24 1993-10-28 Cassella Ag 2,4-Dioxo-imidazolidin-Derivate
DE4224414A1 (de) 1992-07-24 1994-01-27 Cassella Ag Phenylimidazolidin-derivate, ihre Herstellung und ihre Verwendung
DE4228717A1 (de) 1992-08-28 1994-03-03 Cassella Ag Imidazolidin-Derivate
JPH08505628A (ja) 1993-01-08 1996-06-18 田辺製薬株式会社 ペプチド型細胞接着阻害薬
DK0678122T3 (da) 1993-01-12 2000-03-06 Biogen Inc Rekombinante anti-VLA4 antistofmolekyler
CA2155303C (en) 1993-02-09 2010-04-20 Linda C. Burkly Treatment for insulin dependent diabetes
DE4308034A1 (de) 1993-03-13 1994-09-15 Cassella Ag Neue Heterocyclen, ihre Herstellung und ihre Verwendung
DE4427979A1 (de) 1993-11-15 1996-02-15 Cassella Ag Substituierte 5-Ring-Heterocyclen, ihre Herstellung und ihre Verwendung
WO1995015973A1 (en) 1993-12-06 1995-06-15 Cytel Corporation Cs-1 peptidomimetics, compositions and methods of using the same
ES2270425T3 (es) 1994-01-25 2007-04-01 Elan Pharmaceuticals, Inc. Anticuerpos humanizados contra la molecula de adhesion leucocitaria vla-4.
AU2958195A (en) 1994-06-29 1996-01-25 Texas Biotechnology Corporation Process to inhibit binding of the integrin alpha 4 beta 1 to vcam-1 or fibronectin
US5811391A (en) 1994-08-25 1998-09-22 Cytel Corporation Cyclic CS-1 peptidomimetics, compositions and methods of using same
GB9524630D0 (en) 1994-12-24 1996-01-31 Zeneca Ltd Chemical compounds
US6248713B1 (en) 1995-07-11 2001-06-19 Biogen, Inc. Cell adhesion inhibitors
DK0796855T3 (da) 1996-03-20 2002-05-27 Hoechst Ag Hæmmere af knogleresorption og vitronectin-receptorantagonister
PL191082B1 (pl) 1996-07-25 2006-03-31 Biogen Inhibitor IIb/IIIa, sposób jego wytwarzania i jego zastosowanie
DE19647382A1 (de) * 1996-11-15 1998-05-20 Hoechst Ag Heterocyclen als Inhibitoren der Leukozytenadhäsion und VLA-4-Antagonisten
DE19647380A1 (de) * 1996-11-15 1998-05-20 Hoechst Ag 5-Ring-Heterocyclen als Inhibitoren der Leukozytenadhäsion und VLA-4-Antagonisten
DE19647381A1 (de) * 1996-11-15 1998-05-20 Hoechst Ag Neue Heterocyclen als Inhibitoren der Leukozytenadhäsion und VLA-4-Antagonisten
DE19648053C1 (de) 1996-11-20 1998-03-12 Siemens Ag Elektromagnetisches Schaltgerät
WO1998042656A1 (en) 1997-03-21 1998-10-01 Cytel Corporation Novel compounds
DE19741235A1 (de) * 1997-09-18 1999-03-25 Hoechst Marion Roussel De Gmbh Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE19741873A1 (de) * 1997-09-23 1999-03-25 Hoechst Marion Roussel De Gmbh Neue 5-Ring-Heterocyclen, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE19751251A1 (de) * 1997-11-19 1999-05-20 Hoechst Marion Roussel De Gmbh Substituierte Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmezeutische Präparate
DE19821483A1 (de) * 1998-05-14 1999-11-18 Hoechst Marion Roussel De Gmbh Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate

Also Published As

Publication number Publication date
ATE250038T1 (de) 2003-10-15
TWI256386B (en) 2006-06-11
JP2002544261A (ja) 2002-12-24
KR20010113957A (ko) 2001-12-28
DE60005337D1 (de) 2003-10-23
PL351755A1 (en) 2003-06-16
PL201421B1 (pl) 2009-04-30
HU228917B1 (hu) 2013-06-28
IL146276A0 (en) 2002-07-25
BR0011296A (pt) 2002-02-26
HK1047104B (zh) 2006-02-03
HUP0202364A3 (en) 2003-10-28
CN1221535C (zh) 2005-10-05
EP1183241A1 (en) 2002-03-06
SI1183241T1 (en) 2004-02-29
AU4756000A (en) 2000-12-05
CA2373433C (en) 2010-12-14
ES2204595T3 (es) 2004-05-01
HK1047104A1 (en) 2003-02-07
EP1183241B1 (en) 2003-09-17
DE60005337T2 (de) 2004-06-24
NO320687B1 (no) 2006-01-16
CN1356986A (zh) 2002-07-03
TR200103278T2 (tr) 2002-04-22
HUP0202364A2 (hu) 2002-11-28
US6399643B1 (en) 2002-06-04
CA2373433A1 (en) 2000-11-23
NO20015617D0 (no) 2001-11-16
WO2000069831A1 (en) 2000-11-23
AR023989A1 (es) 2002-09-04
ZA200109370B (en) 2002-06-27
DE19922462A1 (de) 2000-11-23
KR100658962B1 (ko) 2006-12-21
DK1183241T3 (da) 2004-01-19
CZ301467B6 (cs) 2010-03-10
NO20015617L (no) 2002-01-15
CZ20014089A3 (cs) 2002-02-13
RU2245879C2 (ru) 2005-02-10
IL146276A (en) 2007-06-03
AU778814B2 (en) 2004-12-23
JP4686029B2 (ja) 2011-05-18
BR0011296B1 (pt) 2011-08-23
PT1183241E (pt) 2004-02-27
NZ515496A (en) 2003-10-31

Similar Documents

Publication Publication Date Title
HUP0105414A3 (en) Pyrrolo-isoquinoline, azepino- and diazepino-indole derivatives, their use and pharmaceutical compisitions containing them
HK1048999A1 (zh) 氮雜䓬吲衍生物，它們的製備和應用
AU3957600A (en) Piperidyl-imidazole derivatives, their preparations and therapeutic uses
ZA200007638B (en) Pyrazoline derivatives, their preparation and application as medicaments.
IL127132A (en) Substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
AU2922600A (en) Pyridopyranoazepine derivatives, preparation and therapeutic use
ZA200003706B (en) Cyclobutene derivatives, their preparation and their therapeutic uses.
HK1019606A1 (en) Novel imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
ZA200001746B (en) 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use.
HUP0302193A3 (en) 1,4-diazabicyclo[3.2.2]nonabenzoxazole, -benzothiazole and benzimidazole derivatives, preparation thereof and pharmaceutical compositions containing them
ZA200110150B (en) Streptogramin derivatives, preparation and compositions containing them.
ZA200203294B (en) N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them.
HK1050003A1 (en) Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them.
HUP0201810A3 (en) Sootepenseone and its derivatives, their preparation and use as medicament
HK1047037A1 (en) Pharmaceutical preparations containing nanosols ofchitosan, and their preparation.
MXPA01011611A (es) Derivados de espiroimidazolidina, su prepracion, su uso y preparaciones farmaceuticas que los comprenden.
ZA200300777B (en) Process for the preparation of peptide salts, their use and pharmaceutical preparations comprising the peptide salts.
ZA200001747B (en) 3-Amino-3-arylpropan-1-ol derivatives, their preparation and use.
ZA9810403B (en) New epothilon derivatives, process for their preparation and their pharmaceutical use.
IL146372A0 (en) Cinnamoylaminoalkyl-substituted benzenesulfonamide derivatives, processes for their preparation, their use and pharmaceutical preparations comprising them
HUP0203557A3 (en) Novel amidine derivatives, preparation and use thereof as medicines
IL132666A0 (en) Phytoestrogenic pharmaceutical preparations
HUP0203455A3 (en) 2-arylquinoline derivatives, preparation and therautic use thereof
AU3971300A (en) 2-aminoethyl-indole derivatives, their preparation and therapeutic use
SI1161434T1 (en) Pyridopyranoazepine derivatives, preparation and therapeutic use

Legal Events

Date Code Title Description
FG Grant or registration
HC Change of company name or juridical status